These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32853691)

  • 1. Development and validation of screening scores of non-alcoholic fatty liver disease in middle-aged and elderly Chinese.
    Liang Y; Ye M; Hou X; Chen P; Wei L; Jiang F; Feng L; Zhong L; Liu H; Bao Y; Jia W
    Diabetes Res Clin Pract; 2020 Nov; 169():108385. PubMed ID: 32853691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
    Li XD; Qiu BH; Su FC; Sun SX
    Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
    Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
    Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
    Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
    Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting.
    Abd El-Wahab EW; Zein El-Abedin RA; Ahmed WM; Shatat HZ
    Am J Med Sci; 2020 Dec; 360(6):662-677. PubMed ID: 32739036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ZJU index is a powerful index for identifying NAFLD in the general Chinese population.
    Li L; You W; Ren W
    Acta Diabetol; 2017 Oct; 54(10):905-911. PubMed ID: 28698957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFI, a clinical scoring tool for predicting non-alcoholic fatty liver in the Chinese population.
    Zhao M; Hu Y; Shi C; Wang K; Li J; Song J; Huo C; Xi Y; Bu S; Huang Q
    Public Health; 2022 Jan; 202():12-17. PubMed ID: 34875531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population.
    Wang J; Xu C; Xun Y; Lu Z; Shi J; Yu C; Li Y
    Sci Rep; 2015 Nov; 5():16494. PubMed ID: 26568423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a non-invasive assessment tool for screening prevalent undiagnosed diabetes in middle-aged and elderly Chinese.
    Wu J; Hou X; Chen L; Chen P; Wei L; Jiang F; Bao Y; Jia W
    Prev Med; 2019 Feb; 119():145-152. PubMed ID: 30594538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study.
    Pan H; Liu B; Luo X; Shen X; Sun J; Zhang A
    Lipids Health Dis; 2023 Nov; 22(1):205. PubMed ID: 38007441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population.
    Pan X; Xie X; Peng H; Cai X; Li H; Hong Q; Wu Y; Lin X; Xu S; Peng XE
    Front Public Health; 2020; 8():220. PubMed ID: 32714888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population.
    Yip TC; Ma AJ; Wong VW; Tse YK; Chan HL; Yuen PC; Wong GL
    Aliment Pharmacol Ther; 2017 Aug; 46(4):447-456. PubMed ID: 28585725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation study of a non-alcoholic fatty liver disease risk scoring model among adults in China.
    Zhang Q; Wong CKH; Kung K; Chan JCY; Sy BTW; Lam M; Xu XG; Yang MF; Yu Y; Lin XP; Lam CLK
    Fam Pract; 2017 Nov; 34(6):667-672. PubMed ID: 28586417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ZJU index: a useful indicator for recognizing insulin resistance in the Chinese general population.
    Ji B; Qu H; Wang H; Wei H; Deng H
    Acta Diabetol; 2016 Oct; 53(5):817-23. PubMed ID: 27393006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between a non-invasive hepatic fibrosis score and urolithiasis among non-alcoholic fatty liver disease (NAFLD) patients in China: a cross-sectional study.
    Qin S; Wang J; Zhou C; Zhang Y; Xu Y; Wang X; Wang S
    BMJ Open; 2019 Aug; 9(8):e027702. PubMed ID: 31471434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
    Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.